Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Session Type:

clear all | select all

Participation Type:

HIVR4P Home

Funding for this conference was made possible in part by 1R13AI136762-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices or organizations imply endorsement by the U.S. Government.

The conference was supported by Gilead, which provided funding. Gilead has had no input into the content of the materials used at this meeting/conference.

Lessons Learned in Implementing & Scaling-up oral PrEP: Q&A

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 1 of 1
Satellite Session: Current State of Play: PrEP Implementation Update and Challenges
Lessons Learned in Implementing & Scaling-up oral PrEP: Q&A
Emily Donaldson
AVAC, United States
Hasina Sudebar
National Department of Health, South Africa
Daniel Were
Jhpiego Kenya, Kenya
Beatriz Grinszteijn
INI, Brazil
John Brooks
US CDC, United States
Olga Denisiuk
Alliance for Public Health, Ukraine
 
Slides + audio
 
 
slides + audio mp3
from HIV Research for Prevention 2018 on 22 October 2018 08:30-11:30
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 1 of 1